Drug Information

Drug General Information
Drug ID
D07FDL
Former ID
DNC012519
Drug Name
N-(2,3-Dihydro-1H-phenalen-2-yl)-acetamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534186]
Formula
C15H15NO
Canonical SMILES
CC(=O)NC1CC2=CC=CC3=C2C(=CC=C3)C1
InChI
1S/C15H15NO/c1-10(17)16-14-8-12-6-2-4-11-5-3-7-13(9-14)15(11)12/h2-7,14H,8-9H2,1H3,(H,16,17)
InChIKey
NSODBKSYAOTJPJ-UHFFFAOYSA-N
PubChem Compound ID
9859366
Target and Pathway
Target(s) Melatonin receptor Target Info Inhibitor [534186]
KEGG Pathway Neuroactive ligand-receptor interaction
Circadian entrainment
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 534186J Med Chem. 1996 Aug 2;39(16):3089-95.Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
Ref 534186J Med Chem. 1996 Aug 2;39(16):3089-95.Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.